MARKET

NXTS

NXTS

Nexentis Technologies Inc
NASDAQ
0.8575
-0.0263
-2.98%
After Hours: 0.8315 -0.026 -3.03% 19:48 10/09 EDT
OPEN
0.8221
PREV CLOSE
0.8838
HIGH
0.9600
LOW
0.8221
VOLUME
178.84K
TURNOVER
--
52 WEEK HIGH
49.00
52 WEEK LOW
0.8221
MARKET CAP
1.25M
P/E (TTM)
-0.0489
1D
5D
1M
3M
1Y
5Y
1D
Nexentis Technologies Unit MitoCareX Bio Launches Its Computational Drug Discovery Infrastructure On Google Cloud Platform
Benzinga · 4d ago
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
Barchart · 4d ago
Nexentis Amends Warrants to Support Nasdaq Compliance
TipRanks · 5d ago
Weekly Report: what happened at NXTS last week (0928-1002)?
Weekly Report · 6d ago
Weekly Report: what happened at NXTS last week (0921-0925)?
Weekly Report · 09/28 09:33
Nexentis Technologies appoints Major to Scientific Advisory Board
TipRanks · 09/24 12:12
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
Barchart · 09/24 06:50
Nexentis subsidiary evaluates ways for obtaining proteins in in-vitro research
TipRanks · 09/23 11:20
More
About NXTS
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.

Webull offers Nexentis Technologies Inc stock information, including NASDAQ: NXTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NXTS stock methods without spending real money on the virtual paper trading platform.